AnaptysBio, Inc. Common Stock (ANAB) is a publicly traded Healthcare sector company. As of May 21, 2026, ANAB trades at $60.06 with a market cap of $1.71B and a P/E ratio of -64.24. ANAB moved +0.50% today. Year to date, ANAB is +39.07%; over the trailing twelve months it is +184.74%. Its 52-week range spans $12.21 to $73.30. Analyst consensus is strong buy with an average price target of $81.27. Rallies surfaces ANAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AnaptysBio, Inc. Common Stock (ANAB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ANAB moved +0.50% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $60.06 |
| Market Cap | $1.71B |
| P/E Ratio | -64.24 |
| EPS | $-0.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $73.30 |
| 52-Week Low | $12.21 |
| Volume | 379.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $232.39M |
| Net Income | $-26.79M |
| Gross Margin | 0.00% |
11 analysts cover ANAB: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $81.27.